Skip to main content
ETST
OTC Life Sciences

Shareholders to Vote on High Executive Compensation, Reverse Stock Split for Uplisting, and Retirement of Super-Voting Shares

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
9
Price
$0.135
Mkt Cap
$38.904M
52W Low
$0.001
52W High
$0.237
52W Position
Off High info
43% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

Summary

Earth Science Tech, Inc. is seeking shareholder approval for an annual meeting agenda that includes a highly controversial executive compensation package, a proposal to eliminate super-voting preferred shares, and a potential reverse stock split for uplisting.


Key Events · Corporate Governance and Compliance · ETST

  • Executive Compensation Vote

    Shareholders will cast a non-binding advisory vote on executive compensation. The proposed cash compensation for the CEO and COO alone totals over $5.7 million, which is approximately 14.75% of the company's current market capitalization, raising significant concerns about capital allocation.

  • Series B Preferred Stock Retirement

    A non-binding advisory vote will be held to allow the Board to propose an offer to purchase and retire the Series B Preferred Stock, which currently grants super-voting powers to the CEO. This could eliminate a controlling voting structure and align shareholder interests.

  • Reverse Stock Split for Uplisting

    Shareholders will vote on a non-binding advisory proposal recommending a reverse stock split if necessary to meet minimum bid price requirements for an uplisting to a higher-tier exchange, indicating a strategic move to enhance market presence.

  • Director Elections and Auditor Ratification

    The annual meeting also includes routine proposals for the election of seven directors and the ratification of Semple, Marchal & Cooper, LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2027.


Analysis · ETST · Life Sciences

This preliminary proxy statement outlines critical proposals for the upcoming annual meeting. The most significant item is the advisory vote on executive compensation, which proposes exceptionally high cash salaries and bonuses for the CEO and COO, totaling over $5.7 million. This represents approximately 14.75% of the company's current market capitalization, raising serious concerns about capital allocation and potential shareholder value erosion, despite the stated goal of avoiding equity dilution. Additionally, shareholders will vote on a proposal to authorize the Board to negotiate the purchase and retirement of Series B Preferred Stock, which currently carries super-voting powers held by the CEO. This move, if approved and executed, would eliminate a controlling voting structure and could be positive for common shareholders by aligning voting rights. A non-binding advisory vote on a reverse stock split, if deemed necessary for an uplisting to a higher-tier exchange, also signals a strategic intent to improve market visibility and liquidity, though reverse splits can be viewed negatively.

At the time of this filing, ETST was trading at $0.14 on OTC in the Life Sciences sector, with a market capitalization of approximately $38.9M. The 52-week trading range was $0.00 to $0.24. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ETST - Latest Insights

ETST
Jul 02, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.135
Real-time Price: $0.135 info
Change: $0 (0%) info
Market Cap: $38.904M info
ETST
Jun 18, 2026, 6:15 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.1799
Real-time Price: $0.135 info
Change: -$0.0449 (-25%) info
Market Cap: $38.904M info
ETST
Jun 18, 2026, 6:06 AM EDT
Filing Type: 10-K
Importance Score:
7
Price at Filing: $0.1799
Real-time Price: $0.135 info
Change: -$0.0449 (-25%) info
Market Cap: $38.904M info
ETST
Jun 10, 2026, 8:43 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.179
Real-time Price: $0.135 info
Change: -$0.044 (-25%) info
Market Cap: $38.904M info
ETST
Jun 10, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.179
Real-time Price: $0.135 info
Change: -$0.044 (-25%) info
Market Cap: $38.904M info
ETST
Mar 24, 2026, 9:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.100
Real-time Price: $0.135 info
Change: +$0.035 (+35%) info
Market Cap: $38.904M info
ETST
Feb 20, 2026, 1:49 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.120
Real-time Price: $0.135 info
Change: +$0.015 (+13%) info
Market Cap: $38.904M info
ETST
Feb 17, 2026, 8:50 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.130
Real-time Price: $0.135 info
Change: +$0.0050 (+4%) info
Market Cap: $38.904M info
ETST
Feb 13, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.130
Real-time Price: $0.135 info
Change: +$0.0050 (+4%) info
Market Cap: $38.904M info
ETST
Jan 06, 2026, 8:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.1344
Real-time Price: $0.135 info
Change: +$0.0006 (+0.45%) info
Market Cap: $38.904M info